Implementing Stratified Followup What can the LCA do to help?
|
|
- Stephanie Bruce
- 8 years ago
- Views:
Transcription
1 Implementing Stratified Followup What can the LCA do to help?
2 Welcome and Aim of the event Mr Nicholas Hyde, LCA Clinical Director
3 Aim of the event To bring together key clinicians, nurses and managers from the three Stratified Follow- up tumour groups, across all the LCA Trusts To share experiences and learn from each other, across tumour groups To understand some of the challenges and issues associated with implementing stratified follow up To provide an opportunity for Trusts to discuss how they will implement stratified follow up, and agree any actions To consider what more the LCA can do to help
4 Context A Model of Care for Cancer services August 2010 Tested by the National Cancer Survivorship Initiative (NCSI)
5 Context Part of the overall LCA Survivorship Pathway Group s remit, closely linked to Holistic Needs Assessment (HNA), treatment summaries, Health and Wellbeing events (and Cancer Care reviews) Key priority area for the LCA (signed off by the Members Board) and for Macmillan (funded LCA Project Manager, and this event) Implementation of stratified follow-up included with cancer commissioning intentions for 2014/2015
6 Why Implement Stratified Follow-up? Natalie Doyle, Nurse Consultant Living with and Beyond Cancer, Royal Marsden Hospital and Chair, LCA Survivorship Pathway Group
7 Background What is a (risk) stratified pathway? The cancer survivorship vision recommends that cancer patients should be assessed following initial treatment and then be assigned a level of risk of developing consequences of treatment or further disease. An individual care plan would then be drawn up addressing the whole range of needs an individual might have after treatment with the aim of minimising risks and supporting the patient to manage on-going conditions. A Model of Care for Cancer Services, 2010
8 What is stratified follow-up? Stratifying patients for follow up according to their risk can ensure that patient needs are better met and that resources are used more efficiently. At the end of treatment, patients no longer have routine follow up appointments. Instead they are educated to self-manage their condition, but if they do have any worrying symptoms, concerns or issues they are able to contact the Trust via a dedicated helpline.
9 Rationale Improved rates for cancer survival/increased life expectancy will require increased capacity for follow up. NHS Improvement piloted risk stratified pathways in breast, colorectal, prostate and lung which provided a national direction for best practice. Model of Care recommendations. No evidence that routine follow-up identifies disease recurrence Patient experience
10 LCA specific background Prior to LCA formation, several Trusts where already involved in national piloting SWLCN had secured a bid for implementation in their area Remaining funding from this was transferred to the LCA: the Clinical Board where clear that this was important Successful bid to Macmillan to extend the project for a further 18 months
11 Three Year View Embed the risk stratified pathways for stable breast, colorectal and prostate cancer patients. Once established the risk stratified pathways can be rolled out to more complex breast, colorectal and prostate patients eg those who have had chemotherapy/radiotherapy if they are thought to be clinically appropriate. Low risk patients from other tumour groups could also be considered and liaison with Pathway Groups should be instigated to identify relevant patient cohorts.
12 Progress to date LCA wide visits to Trusts to meet Lead Cancer Nurses and CNSs - Engagement - Buy-in - Identifying obstructions to implementation - Sharing existing good practice Engagement of Clinical Pathway Groups Formation of a Risk Stratified Pathway User Involvement Group - Involve Pathway Group Users - Engagement with national charities eg Prostate Cancer UK Development of a pilot implementation pack for Trusts to modify and use. This includes: - Information for patients and GPs - Standard letters
13 No of patients seen 13 The London Cancer Alliance West and South Number of follow-up appointments booked per consultant before and after OAFU Jun-11 Sep WA NR JER WCY/PB Consultant
14 Benefits and challenges Benefits Patients Positive experience of care Less inconvenience Increased awareness about warning signs and symptoms Assurance of a fast way back into the Trust Trusts Reduction of new to follow up ratios Improved performance GPs/Commissioners More streamlined process Savings Improved patient experience Challenges Manpower CNS/Administrative IT Levels of commitment Ensuring clinical governance is robust Financial and logistical implications
15 Summary Stratified pathways are a model of care recommendation They seem to offer a solution to the problems of overflowing out-patient clinics People have been positive about how they work in practice Patient experience is improved National piloting has been successful, including in LCAbased sites
16 Q and A session Identification of issues and challenges Chair: Nicholas Hyde, LCA Clinical Director
17 Success Stories
18 Risk stratified pathways Open access follow up Anne Mc Loughlin-Advanced nurse practitioner Kelly Collins-Database Manager
19 Contents Outline of OAFU at RMH Key factors that led to successful implementation Major challenges
20 Open access follow up breast patients A brief guide A brief guide Pt has recently completed treatment Patient is on traditional routine follow up Pt discussed MDM Suitability for OAFU agreed Team responsible for administering last treatment (surgery, chemo, radiotherapy) arranges appt in OAFU clinic for three months time OAFU clinics: X2 clinics each site each week OAFU consultation takes place: diagnosis, treatment +side effects discussed. Plan for surveillance; mammos DEXA Patient scans + details endocrine are entered treatment on discussed database + documented Key future events are flagged All patients completing five years of mammographic surveillance and endocrine treatment are discussed in virtual MDM- patients and GP If patient on traditional routine follow up is suitable for OAFU-book to clinic Patients return to hospital for mammo and receive results letter by post Patient reports new symptoms to ANP Appropriate clinic appt arranged or referral to
21
22 The OAFU Consultation your diagnosis, treatment and potential side effects plan for mammography, endocrine tx and DEXA scans signs and symptoms to report support after treatment has finished healthy living once tx has completed how to contact us
23 Patient information End of treatment summary If cancer returns: signs and symptoms Side effects of treatment Anti- hormone therapy Mammograms Breast cancer under 45 Breast Cancer Care Moving Forward Folder Macmillan: Managing the late effects of treatment
24 Remote monitoring paper based requested at entry in to OAFU and each year after identify patients no longer active following new diagnosis/recurrence or discharge to G.P use of EPR appointments for preparing monthly virtual MDT meetings reliant on a data base manager
25 Progress to date over 3228 pts are enrolled 1359 diagnosed less than one year from diagnosis 1869 transferred from traditional follow up Imaging surveillance: 135 pts a month Sutton 57 pts a month Chelsea M3 meeting: 9 pts a month Sutton 3 pts a month Chelsea 49 pts currently deferred mammos DEXA scans: 403 Sutton, 242- via GP
26
27 No of tel calls: 2013
28 Telephone queries
29 Virtual MDM To identify and inform patients: that no further treatment or imaging is required beyond the five year mark who may benefit from extended hormone treatment, or switching of endocrine treatment with a family history of breast cancer who may require additional screening Exclusion criteria: Grade 1 or 2 tumours, negative nodes, er positive, Her 2 +ve, LVI positive, node positive, Her 2 negative
30 Challenges would pts accept a self care approach? would the clinical teams feel confident? how would we track mammos, endocrine tx, DEXA scans? limitations of existing IT systems and paperwork managing phone calls: reassurance vs new/ local metastatic disease
31 Factors that led to successful implementation Involvement of the whole team CQUIN target Small dedicated team to manage day to day running Constant liaison with different groups of staff Awareness of additional resources for patients at End of Treatment
32 Benefits patients have sufficient information knowledge, support and confidence to self manage reduction in routine follow up appts uniformity of follow up care
33 Telephone audit The London Cancer Alliance West and South To assess if the introduction of oafu had increased the no of calls to the BCN 8 BCN took part over a one month period 2011: 265 calls in total 2013: 401 calls in total (136 from pts who had completed treatment for breast cancer)
34 Patient satisfaction audit Aim: to assess satisfaction with OAFU including how well pts understood the written information, how confident they were about re- accessing the breast team and supported self management QN sent to 200 pts 81 returned, majority of respondents were white and post menopausal
35 The plan for my follow up care was clearly explained and I understood what would happen No of replies: 81 90% strongly agreed or agree
36 I was content with not receiving regular appts within the breast clinic No of replies: % strongly agreed or agree
37 The information discussed made me feel less anxious No of replies: 81 56% strongly agreed or agreed
38 I received enough practical advice and information about life after cancer treatment No of replies: 76 47% strongly agreed or agreed
39 I felt confident that I could contact the team as required No of replies: 77 77% strongly agree or agree
40 The Future implementation of a system to replace the current excel database using hospital patient pathway system an electronic patient summary within EPR system an automated production of patient mammogram letters updating and refining patient information, guidelines and protocols Patient experience of oafu
41 PSA Tracker A Remote Follow Up Service Matthew Perry St George s Hospital, London Matthew.perry@stgeorges.nhs.uk
42 St George s Experience High level of involvement Clinical champion eg Consultant Patient involvement IT lead for Trust Pathology technical lead for trust Funding ( 6K) Project Lead
43 Infloflex at MDT Activate Patient EP R Tracker Pathology lab PSA form Patient letter GP letter
44 St George s Experience Patient added to MDT meeting via Infoflex Automatically added to Tracker system via infoflex Patient activated following clinical discussion and consent PSA test form given Notices set up, PSA time and value (Alerts) Weekly review of database for alerts/replies Letters/telephone calls activated.
45 St George s Experience Pitfalls and Solutions Weekly virtual clinics Renumeration Pathology laboratory Clinical champion bedding in to BAU IT troubleshooting Set time aside in Job Plan CCG discussion A London issue? Identify wins early Clinical engagement Money helps!
46 St George s Experience Project Manager Clear patient benefits Clear clinician benefits Clear commissioner benefits Good Governance Not for all patients Re-entry pathways need to be clear
47 Risk stratification: Colorectal cancer Claire Taylor Macmillan Lead Nurse Colorectal Cancer St Mark s Hospital
48 48 The London Cancer Alliance West and South Aims of colorectal cancer follow-up care To improve survival detection of recurrent disease To improve quality of life - management of any treatment complications Support and reassurance Audit Among patients who had undergone curative surgery for primary colorectal cancer, the screening methods of CT and CEA each provided an improved rate of surgical treatment of cancer recurrence compared with minimal follow-up, although there was no advantage in combining these tests, FACS trial, JAMA 2014
49 49 The London Cancer Alliance West and South Rationale for risk-stratification Responsive to individual needs e.g. can facilitate access to specialist care when needed. Risk stratification dependent on need: self management, shared care or complex Based on an ethos of partnership and peer support Aiming to embrace 5 shifts i.e. consideration to consequences of cancer treatment, using PROMs
50 5 key shifts 1. a greater focus on recovery, health and well-being after cancer treatment. 2. holistic assessment, information provision and personalised care planning. 3. Supported self-management 4. away from clinical follow up to tailored support that enables early recognition of the consequences of treatment and the signs and symptoms of further disease. 5. measuring experience and outcomes
51 51 Lifestyle interventions Treatment record summary GP Cancer care review Support groups Assessment & care planning Individualised after-care
52 St Mark s pilot stratified follow-up pilot for low risk colorectal cancer patients Supported self-management Complex care
53 Establishing the clinic Examined current follow-up care pathways for patients with colorectal cancer Reviewed evidence and seek patient feedback Estimated patient numbers Determined key quality indicators Met with stakeholders Wrote a project plan
54 Criteria for supported self-management completed curative treatment a T 1, T 2, T 3 N 0 cancer no significant surgical complication willingness will be put on pathway
55 Patient numbers 300+ new patients a year 30% may be eligible: excludes private patients, those with severe learning disabilities or mental health issues and patients on clinical trials Across 4 Consultants = 100 patients a year plus any who can step down
56 Patient feedback 8 Trust Cancer user group members? In the community What if no services available locally to meet need. Stoma support group: 12 Inside Out members support should be gradually decreased and withdrawn only when the patient felt ready Individual discussions with 8 patients who indicated overall satisfaction with current service but for some: a preference for greater continuity A need for peer support Some dependence upon the Consultant Delays in getting appointments and results
57 Setting of standards All patients are offered a full holistic needs assessment & survivorship care plan All patients receive agreed surveillance protocol All patients are offered core written information All patients receive offer of further support All patients seen in surgical clinic in 2 weeks if symptoms develop
58 How to make it happen Training: MI, IRMER, ICS, Dragon Team work Management support Securing and developing resources
59 IT software development Results look-up Alerts for limits Consultant notified if anything acute CNS checks results GP and patient notified by letter Next test booked
60 Major Challenge 1 Engaging and convincing commissioners: What does this mean for us? Level of on-going contact Management of symptoms Who should manage these symptoms
61 61 The London Cancer Alliance West and South Shift 1: Recovery package
62 CRC MDT identify patients who meet criteria to enter list to identify possible e- HNA assessment 10 mins CNS undertakes virtual clinics every week and reviews all patients on programme to see when planned surveillance due and if results are available they are viewed and actioned. Only once letters sent out to pt and GP can next surveillance test be booked. Over 5 years Decision recorded on patient s MDT Proforma. Patient informed of this decision at first postoperative OPD and verbal consent gained Patient sent letter by CNS inviting them to join the selfmanagement programme CNS: invites patient to attend the HNA clinic and undertake e-hna Patient completes e-hna assessment. CNS: Discussion of patient s needs and care planning care Patient put on to telephone follow-up and invited to attend Reach for recovery Self-management box is ticked on GCIS for each patient to activate remote surveillance - can be taken off if they decline Send to patient: Introduction letter, HNA booklet and flier about Reach for Recovery. Send letter to GP about pathway Clinic Clerk makes 6/52 OPA for HNA clinic In St Marks out-patient clinic. Patient offered information on Living with cancer, Health promotion, Top Tips, further sources of support etc CNS plans formal telephone clinic dates with patients and documents updates in GCIS
63
64 Resources in clinic Explaining how to take Loperamide (Imodium)
65
66 66 Shift 2. Holistic assessment and care planning BOWEL FUNCTION PAIN FEAR OF RECURRENCE COGNITIVE CONCERNS 3 FAMILY CONCERNS TIREDNESS 3 6 DIET 4 5 EXERCISE 4 4 BODY IMAGE SEXUAL ISSUES N=11
67 Major Challenge 2 Fitting this into day job 1 patient = 2 hours per 1 st visit Co-ordination Employed part-time Band 4 but long orientation required Administration No secretarial support. Need for virtual clinic
68 Shift 3: Components of Cancer Survivor Self-Management (Foster et al., 2009) Problems After Cancer Treatment Effects of treatment Abandonment Lack of information Lack of support Emotional difficulties Social/relationship difficulties Physical/functional changes Sources of Self Management Support Healthcare workers Families & friends Accessing information Networking with other cancer survivors Work & finance Organised support Self Management Strategies Psychological problems: Altered outlook/priorities Managing emotions Self resourcefulness Social problems: Proactive socialising Sharing experience Resisting contact Managing work/finance Physical problems: Simple strategies Complex strategies Problem Resolution LIVE WELL AFTER CANCER External Resources Personal Resources what health services do to aid and encourage people living with a long term condition, to make daily decisions that improve health related behaviours, and clinical and other outcomes. (NCSI Self-Management Workstream, adapted from Co-Creating Health, The Health Foundation, 2008).
69
70 70 The London Cancer Alliance West and South Shift 4: from follow-up to after-care To ensure those living with and beyond cancer get the care and support they need to lead as healthy and active a life as possible, for as long as possible NCSI, 2010
71 Reach for recovery FOLLOWING BOWEL CANCER TREATMENT
72 72 The London Cancer Alliance West and South Session Content 1 Introduction and overview of colorectal cancer and its treatments. What is normal recovery? 2 Managing your body and its symptoms. What is selfmanagement? 3 Recognising and managing emotions. Coping with feelings, financial concerns and return to work. 4 How to increase your activity levels What are the benefits and barriers to being active? 5 Finding a diet that is right for you. 6 Talking to doctors and nurses and finding further support on Living beyond cancer
73 6 months on experiences Difficulties Clinic coding telephone clinic Timing of clinic Time spent on administration Advantages 1hr consultation Therapeutic role Timely review of patient concerns Flexibility for pts
74 The initiative cycle Implement Investigate Innovate How long will change take?
75 Shift 5: Monitoring and measuring Monthly reviews during initiation Share experiences Seek continuous feedback: value compliments as well as learn from complaints/ mistakes PROMS
76 Next steps Feedback to commissioners and clinicians Further roll out once CNS sufficiently resourced Modify Health and Well-being event Treatment summary
77 77 The London Cancer Alliance West and South Value of risk stratification Redesigning follow up will enable clinicians to spend more time with complex patients Changes emphasis of follow-up care Supports patients in self-management Releases savings estimated to be 98 per FU
78 What will success look like? Risk stratification implemented A 50% reduction in outpatient attendances from the traditional model An improvement in the experience and patient reported outcomes of care from baseline A 10% reduction in unplanned admissions from baseline.
79 IT Issues and Solutions
80 Cancer Remote ST George s NHS Trust: IT Issues and Solutions Justin Beardsmore St George s NHS Trust Implementation Technical Lead
81 Installation and Setup NBT installed Application via N3. We provided a virtual server & MS SQL DB instance. A few glitches but NBT resolved without our assistance. Installation time was a little more than half-aday, but shouldn't be going forward.
82 Data Interfaces
83 On-going support requirements Trust IT to support infrastructure and data imports. Urology department manages application (users/passwords). Other departments to take responsibility for providing extracts. Supplier (NBT) to manage application roadmap.
84 Tracker Limitations of use HL7 Interface on wish list, but Bulk Import process meets present needs (low maintenance, weekly clinic). Multi lab functionality Urban area s where GP s have the choice of using a number of hospitals for test results. South West London Pathology Project will resolve this issue. Need to clarify support agreement.
85 Risk stratified pathways Open access follow up Data Collection Kelly Collins - Data Manager
86 Contents OAFU database Administration / Workload Virtual MDT Patients taken off remote monitoring OAFU database - benefits OAFU database - challenges Remote monitoring - Future
87 Open Access follow up - Remote monitoring Since the rollout of OAFU at the end of 2010 approximately 3300 patients have been entered. There are currently around 2500 patients active with access back to the breast team if required. As patients no longer attend for clinical review, the OAFU database was created to remotely monitor patients.
88 Open Access database Record all breast patients on OAFU Track annual appointments Alert team of outstanding investigations and results Highlight patients who are due for review Identify patients who are coming to the end of their follow up and treatment pathway
89 Open Access database Patients on annual recall for mammography MRI and ultrasound in addition to mammography Endocrine review and switch DEXA scans - 2 yearly if taking an AI endocrine Clinic appointments for results and oncology review Urgent investigations
90 Administration / Workload Mammogram results Mammogram appointment sent to patient Patient attends for mammogram Patient does not attend (DNA). Further appointment sent Fails to attend 2 appointments. No further appt made. Deferred Normal result No Discussed in M3 meeting and contacted by ANP with outcome Yes Standard letter generated and sent with appointment for following year. If having final mammogram advised to re-join NHSBSS if required Further views. U/S or biopsy CNS contacts patient with result Normal / Benign New cancer / Recurrence / Metastatic Off tracking
91 Administration / Workload Monthly tracking Mammograms MRI DEXA scans Endocrine review U/S 190
92 Virtual MDT Virtual MDT discusses patients who are: Due to complete 5 years of endocrine Endocrine due to be switched at 2 3 year mark Requiring additional screening
93 Virtual MDT - Criteria Grade 2 or 3 Size: 20mm or more LVI: Present Node positive Strong family history to discuss extended screening
94 Virtual MDT preparation Patient list circulated to VMDT members Presented using PowerPoint Generated from patient EPR
95 Virtual MDT - Template Patient details: Discussion: Site: Hospital number : Name. DoB: 5 year endocrine review / Switch review / screening plan Sutton / Chelsea Consultant Diagnosis: Management: Histology: Date diagnosed tumour type and side Date of surgery, type of surgery and neo-adjuvant treatment if undertaken ER, PgR and Her2 receptor status. Histology: Tumour type, grade, Size, nodes. Pathology taken from patient path report. Adjuvant treatment: Date of chemotherapy, radiotherapy and adjuvant endocrine Clinical trials: Family history: Screening: Outcome: Details of any trials related to breast Details of family history of breast cancer Mammography screening plan and results of last DEXA scan if undertaken. Agreed outcome recorded
96 Patients taken off remote monitoring Discharged Not on endocrine completed 5 years of screening and is over age 50 Discussed in Virtual MDT screening complete on extended endocrine Discussed in Virtual MDT endocrine complete Off tracking New cancer or recurrence Metastatic disease Deceased BRCA carrier Clinical decision
97 OAFU database - benefits Has enabled breast unit to decide what data capture is required and expand on this as the OAFU programme has progressed A quick method of implementing a system to remotely monitor patients Easy to implement with limited IT resources
98 OAFU database - challenges Not an automated system creating large administrative workload Duplication of data entry Not a fully robust system easy to delete information Supporting an increasing amount of data
99 Remote monitoring - Future Full implementation of in-house database by next year to create: Automated reporting system Automated tracking system and date alerts An electronic patient summary integrated with EPR and in house database Less reproduction of data entry More streamlined remote monitoring tool
100 Group Discussions (in Trust Groups) What have I learned today that I can take back to my Trust? What challenges do we see? How will we tackle these? What 3 things will we do next to take forward Stratified Follow up? What more can the LCA do to help?
101 Summary and Finish Chair: Nicholas Hyde
Breast Cancer Pathway
Breast Cancer Pathway Risk Stratified Follow Up Dr Dorothy Goddard, Associate Medical Director for Cancer Macmillan Consultant Medical Advisor Survivorship What is risk stratified follow up? Refers to
More informationINDICATIVE ROLE SPECIFICATION FOR A MACMILLAN CANCER SUPPORT WORKER - CARE COORDINATION
INDICATIVE ROLE SPECIFICATION FOR A MACMILLAN CANCER SUPPORT WORKER - CARE COORDINATION August 2011 Introduction and context Macmillan has been working with the Department of Health in England (DHE) and
More informationGuideline for the Follow Up of Patients Following Treatment for Breast Cancer
Guideline for the Follow Up of Patients Following Treatment for Breast Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Page 1 of 6 1 Scope of the Guideline This guideline
More informationOVARIAN CANCER TREATMENT
OVARIAN CANCER TREATMENT Cancer Care Pathways Directorate Tailored Information in Cancer Care (TICC) Sir Anthony Mamo Oncology Centre National Cancer Plan May 2015 Contents About this booklet 1 The Ovaries
More informationSix Month Pilot Analysis: Improving Rehabilitation for Men with Prostate Cancer in North East London
Six Month Pilot Analysis: Improving Rehabilitation for Men with Prostate Cancer in North East London June 2015 Helen Whitney (Physiotherapist and Prostate Cancer Project Lead) Thufayel Islam (Prostate
More informationPatient Electronic Alert to Key-worker System (PEAKS) Guidelines
Patient Electronic Alert to Key-worker System (PEAKS) Guidelines This procedural document supersedes: PAT/EC 4 v.1 Guidelines for Patient Electronic Alert to Key-worker systems (PEAKS). Did you print this
More informationPRIMARY LUNG CANCER TREATMENT
PRIMARY LUNG CANCER TREATMENT Cancer Care Pathways Directorate Tailored Information in Cancer Care (TICC) Sir Anthony Mamo Oncology Centre December 2014 Contents About this booklet 1 Types of Lung Cancer
More informationThis vision does not represent government policy but provides useful insight into how breast cancer services might develop over the next 5 years
Breast Cancer 2015 Annex C Background 1. Breast cancer is the most common cancer in women in England with (not including cases of ductal carcinoma in situ (DCIS) 1 ) 39,681 new cases diagnosed in 2008
More informationTransforming Care After Treatment and the Ayrshire Experience
Transforming Care After Treatment and the Ayrshire Experience The overall aim of the programme is to ensure that people affected by cancer in Scotland, are prepared and supported to live with the consequences
More information2010 National Survey. Newham University Hospital NHS Trust
National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department
More informationHow To Prepare A Meeting For A Health Care Conference
THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY EXECUTIVE SUMMARY 1. All patients in Lothian with thoracic malignancies should be discussed at designated times in pathway (see App
More informationSharing good practice
Macmillan Cancer Support 2013. Permission granted for use as seen, this notice must remain intact in all cases. All rights reserved. Introduction The Recovery Package is a series of key interventions which,
More informationFollow-up care plan after treatment for breast cancer. A guide for General Practitioners
Follow-up care plan after treatment for breast cancer A guide for General Practitioners This leaflet provides information for GPs on the follow-up care required by women who had breast cancer. It is for
More informationThe RADICALS trial Radiotherapy Timing Randomisation (RADICALS-RT) Clinical trial of treatment after surgery for prostate cancer
Stoke Mandeville Hospital Mandeville Road Aylesbury Buckinghamshire HP21 8AL Tel: 01296 315 908 www.buckshealthcare.nhs.uk The RADICALS trial Radiotherapy Timing Randomisation (RADICALS-RT) Clinical trial
More informationBREAST CANCER TREATMENT
BREAST CANCER TREATMENT Cancer Care Pathways Directorate Tailored Information in Cancer Care (TICC) Sir Anthony Mamo Oncology Centre December 2014 Contents About this booklet 1 Your First Oncology Consultation
More informationThe Role of the MDT Coordinator. Laura Throssell
The Role of the MDT Coordinator Laura Throssell NHS Cancer Plan (2000) the care of all patients with cancer should be formally reviewed by a specialist team. all patients have the benefit of the range
More informationA step by step introduction to setting up and running a successful nurse-led clinic in practice
A step by step introduction to setting up and running a successful nurse-led clinic in practice Alison Pottle Nurse Consultant in Cardiology Royal Brompton and Harefield NHS Foundation Trust Harefield
More informationEvaluation of the Transforming Cancer Follow-Up Programme
www.pwc.co.uk Evaluation of the Transforming Cancer Follow-Up Programme Wave 1 Evaluation Report August 2013 Final Report Acknowledgements The evaluation team is grateful to all those who have contributed
More informationHow To Manage A Hospital Emergency
ENHANCED SERVICE SPECIFICATION RISK PROFILING AND CARE MANAGEMENT SCHEME Introduction 1. This enhanced service has been designed by the NHS Commissioning Board (NHS CB) to reward GP practices 1 for the
More informationCancer research in the Midland Region the prostate and bowel cancer projects
Cancer research in the Midland Region the prostate and bowel cancer projects Ross Lawrenson Waikato Clinical School University of Auckland MoH/HRC Cancer Research agenda Lung cancer Palliative care Prostate
More informationOther Clinical Support services available on site include Oncology, Laboratory, Pharmacy, Physiotherapy and Audiology.
BMI Albyn Hospital Quality Accounts April 2013 to March 2014 ALBYN HOSPITAL BMI Albyn Hospital is part of BMI Healthcare a leading provider of healthcare services throughout the UK. Located in the west
More informationInvasive lobular breast cancer
Invasive lobular breast cancer This booklet is about invasive lobular breast cancer. It describes what invasive lobular breast cancer is, the symptoms, how it s diagnosed and possible treatments. Diagnosed
More informationRapid review of current service provision following cancer treatment
NHS NHS Improvement CANCER DIAGNOSTICS NHS Improvement Rapid review of current service provision following cancer treatment HEART LUNG STROKE Acknowledgement NHS Improvement would like to thank all the
More informationThe Center for Prostate Cancer. Personalized Treatment. Clinical Excellence.
The Center for Prostate Cancer Personalized Treatment. Clinical Excellence. The Center for Prostate Cancer Leaders in Prostate Cancer Treatment and Research The Center for Prostate Cancer at the North
More informationAdvanced Nurse Practitioner Specialist. Palliative
JOB DESCRIPTION ellenor Advanced Nurse Practitioner Specialist Palliative Care Responsible to Accountable to: Head of Adult Community Services Director of Patient Care General ellenor is a specialist palliative
More informationHow To Manage A Cancer Oncology Clinic
GYNAECOLOGICAL ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY Version 3 Policy agreed Sept 2009 (updated Jan/Feb 2013) Agreed by: SCAN gynae group 2009 Update agreed SCAN gynae group May
More informationStoma Care Clinical Nursing Standards
Stoma Care Clinical Nursing Standards Introduction A standard is a level of quality against which performance can be measured. It can be described as essential - the absolute minimum to ensure safe and
More informationJoint Surrey Carers Commissioning Strategy for 2012/3 to 2014/5 Key Priorities for Surrey Multi Agency Delivery Plan - May 2012
Joint Surrey Carers Commissioning Strategy for 2012/3 to 2014/5 Key Priorities for Surrey Multi Agency Delivery Plan - May 2012 Note this Delivery Plan will be updated & republished 3 times a year throughout
More informationA practical guide to living with and after cancer. Front Cover
A practical guide to living with and after cancer Front Cover 2 What to do after cancer treatment ends 10 top tips After cancer treatment, it helps to know what to expect and where you can get further
More informationSurvivorship Care Plans Guides for Living After Cancer Treatment
Survivorship Care Plans Guides for Living After Cancer Treatment Institute of Medicine Report 2005 Recommendations for meeting needs of cancer survivors Implement survivorship care plan Build bridges
More informationXerox Custom Healthcare Solution
Xerox Custom Healthcare Solution Xerox HR Services has undertaken a comprehensive review of the employee benefits market, assessing all of the major providers, in order to develop our Xerox Custom Healthcare
More informationThere are many different types of cancer and sometimes cancer is diagnosed when in fact you are not suffering from the disease at all.
About Cancer Cancer is a disease where there is a disturbance in the normal pattern of cell replacement. The cells mutate and become abnormal or grow uncontrollably. Not all tumours are cancerous (i.e.
More informationCoventry and Warwickshire Repatriation Programme
NHS Arden Commissioning Support Unit Coventry and Warwickshire Repatriation Programme Large-scale service redesign and innovation to benefit patients Arden Commissioning Support Unit worked with Coventry
More informationAVOIDING UNPLANNED ADMISSIONS ENHANCED SERVICE: PROACTIVE CASE FINDING AND CARE REVIEW FOR VULNERABLE PEOPLE GUIDANCE AND AUDIT REQUIREMENTS
April 2014 AVOIDING UNPLANNED ADMISSIONS ENHANCED SERVICE: PROACTIVE CASE FINDING AND CARE REVIEW FOR VULNERABLE PEOPLE GUIDANCE AND AUDIT REQUIREMENTS A programme of action for general practice and clinical
More informationBOARD PAPER - NHS ENGLAND. Purpose of Paper: To inform the Board about progress on implementation of the Cancer Taskforce report.
Paper: PB.28.01.16/05 Title: Cancer Taskforce strategy implementation Lead Director: Bruce Keogh, National Medical Director Cally Palmer, National Cancer Director BOARD PAPER - NHS ENGLAND Purpose of Paper:
More informationBOARD PAPER NHS ENGLAND
Paper 1505142 BOARD PAPER NHS ENGLAND Title: Patient and Public Voice From: Tim Kelsey, National Director for Patients and Information Purpose of paper: NHS England is committed to: promoting and upholding
More informationExecutive Summary and Recommendations: National Audit of Learning Disabilities Feasibility Study
Executive Summary and Recommendations: National Audit of Learning Disabilities Feasibility Study Contents page Executive Summary 1 Rationale and potential impact of a future audit 2 Recommendations Standards
More informationSharing good practice
Sharing good practice Noëline Young Project Manager, National Cancer Survivorship Initiative Dr Alastair Smith Honorary Consultant Haematologist and Clinical Adviser for Macmillan Cancer Support Louise
More informationA guide to prostate cancer clinical trials
1 A guide to prostate cancer clinical trials In this fact sheet: What is a clinical trial? Why are trials done? What are trials looking into at the moment? How are clinical trials done? Should I take part
More informationGuide to Private Medical Insurance
Guide to Private Medical Insurance Contents About the Exeter 4 Why private medical insurance? 5 Product highlights 6 Cover and benefits 10 Getting the right premium 15 How to apply 16 Claims overview 21
More informationMeasuring quality along care pathways
Measuring quality along care pathways Sarah Jonas, Clinical Fellow, The King s Fund Veena Raleigh, Senior Fellow, The King s Fund Catherine Foot, Senior Fellow, The King s Fund James Mountford, Director
More informationBreast Cancer. Presentation by Dr Mafunga
Breast Cancer Presentation by Dr Mafunga Breast cancer in the UK Breast cancer is the second most common cancer in women. Around 1 in 9 women will develop breast cancer It most commonly affects women over
More informationImproving Services for Patients with Learning Difficulties. Jennifer Robinson, Lead Nurse Older People and Vulnerable adults
ENC 5 Meeting Trust Board Date 18 th December 2014 Title of Paper Lead Director Author Improving Services for Patients with Learning Difficulties Kathryn Halford, Director of Nursing Jennifer Robinson,
More informationLung Cancer Multidisciplinary Meeting Toolkit. National Lung Cancer Working Group
Lung Cancer Multidisciplinary Meeting Toolkit National Lung Cancer Working Group September 2014 Contents Introduction 1 Multidisciplinary meetings 1 Toolkit for implementing high-quality lung cancer MDMs
More informationTubular breast cancer
Tubular breast cancer This booklet is for people who would like more information about tubular breast cancer. It describes what tubular breast cancer is, its symptoms, how a diagnosis is made and the possible
More informationPhyllodes tumours: borderline malignant and malignant
Phyllodes tumours: borderline malignant and malignant This booklet is for people who would like more information on borderline malignant or malignant phyllodes tumours. It describes what they are, the
More informationThe London Cancer Experience Using The National Cancer Patient Experience Survey to improve cancer services across London
The London Cancer Experience Using The National Cancer Patient Experience Survey to improve cancer services across London Dr Theresa Wiseman Lead for Health Service Research, The Royal Marsden NHS Foundation
More informationHIV Outpatient Clinical Care Pathway Version 11 [As per 10 updated for documentation review]
HIV Outpatient Clinical Care Pathway Version 11 [As per 10 updated f documentation review] Categy 1: New Categy 2: Stable Categy 3: Complex - ACCESS HIV + Diagnosis Patient from: G.U. clinic A&E Medical
More informationNational Bowel Cancer Audit Report 2008 Public and Executive Summary
National Bowel Cancer Audit Report 2008 Public and Executive Summary Prepared in association with: Healthcare Quality Improvement Partnership HQIP Association of Coloproctology of Great Britain and Ireland
More informationJOB DESCRIPTION. ellenor. Head of Adult Community Services Director of Patient Care
JOB DESCRIPTION ellenor Clinical Nurse Specialist Responsible to: Accountable to: Head of Adult Community Services Director of Patient Care General ellenor is a specialist palliative care provider for
More informationPSA Testing for Prostate Cancer An information sheet for men considering a PSA Test
PSA Testing for Prostate Cancer An information sheet for men considering a PSA Test What is the aim of this leaflet? Prostate cancer is a serious condition. The PSA test, which can give an early indication
More informationHip replacements: Getting it right first time
Report by the Comptroller and Auditor General NHS Executive Hip replacements: Getting it right first time Ordered by the House of Commons to be printed 17 April 2000 LONDON: The Stationery Office 0.00
More informationThe role of the Specialist Nurse Practitioner for Late Effects Information for patients
Oxford University Hospitals NHS Trust The role of the Specialist Nurse Practitioner for Late Effects Information for patients This leaflet describes the role of the Specialist Nurse Practitioner for Late
More informationThe Role of Clinical Practice Guidelines, Survivorship Care Plans, and Inter-sectoral Care in Cancer Rehabilitation
The Role of Clinical Practice Guidelines, Survivorship Care Plans, and Inter-sectoral Care in Cancer Rehabilitation Prof. Eva Grunfeld, MD, DPhil, FCFP Ontario Institute for Cancer Research/Cancer Care
More informationLung Cancer & Mesothelioma 2011-2015
Lung Cancer & Mesothelioma 2011-2015 Annex G Mesothelioma 1. The vision for mesothelioma services is set out in the Mesothelioma Framework issued by DH on 26 February 2007 (supported by the British Thoracic
More informationA - DASH 15 Forest Lane Shenley, Nr Radlett Hertfordshire WD7 9HQ 01923 427 288 A-DASH@hertspartsft.nhs.uk
A-DASH is commissioned by the Joint Commissioning Group for Young People s Substance Misuse, a sub group of Hertfordshire Children s Trust Partnership. The service is based within Hertfordshire Partnership
More informationAdvanced Nurse Practitioner Adult Specialist Palliative Care
JOB DESCRIPTION ellenor Advanced Nurse Practitioner Adult Specialist Palliative Care Responsible to Accountable to: Head of Adult Community Services Director of Patient Care General ellenor is a specialist
More informationHow do I find the best place to get treatment for my lymphoma?
Produced November 2010 Next revision due November 2012 How do I find the best place to get treatment for my lymphoma? Introduction Fortunately this is not a question that patients with cancers of the blood
More informationJSNA Factsheet Template Tower Hamlets Joint Strategic Needs Assessment 2010 2011
JSNA Factsheet Template Tower Hamlets Joint Strategic Needs Assessment 2010 2011. Executive Summary This fact sheet considers breast cancer, with a particular emphasis on breast screening and raising awareness
More informationEvolving Pathways of Care
Evolving Pathways of Care Nicola Glover, Project Manager LCA Jan Morrison, Macmillan Lead Cancer Nurse Charmaine Case. Breast Care Nurse. St George s Hospital 33 Survivorship- a definition cover[ing] the
More informationBreast Unit Patient Information
Open access follow-up after treatment for primary breast cancer Breast Unit Patient Information This information is for patients in our breast open access follow up programme The open access follow up
More informationHereditary Breast and Ovarian Cancer (HBOC)
Oxford University Hospitals NHS Trust Oxford Regional Genetic Department Hereditary Breast and Ovarian Cancer (HBOC) Information for women with an increased lifetime risk of breast and ovarian cancer What
More informationSOMERSET DEMENTIA STRATEGY PRIORITIES FOR 2013 2016
SOMERSET DEMENTIA STRATEGY PRIORITIES FOR 2013 2016 October 2013 1 CONTENTS PAGE Section Contents Page Somerset Dementia Strategy Plan on a Page 3 1 Introduction 4 2 National and Local Context 5 3 Key
More informationHealth Policy & Scrutiny Urgency Sub-Committee MINUTES OF PROCEEDINGS
CITY OF WESTMINSTER MINUTES Health Policy & Scrutiny Urgency Sub-Committee MINUTES OF PROCEEDINGS Minutes of a meeting of the Health Policy & Scrutiny Urgency Sub-Committee Committee held on Thursday 7th
More informationOncology Medical Home Measure Specification Data
Oncology Medical Home Measure Specification Data Measure Name Chemotherapy pathway compliance Measure # 1 Measure Description % of chemotherapy treatments that have adhered to NCCN guidelines or pathways.
More informationNATIONAL STATISTICS TO MONITOR THE NHS CANCER PLAN - REPORT OF A PRE SCOPING STUDY
NATIONAL STATISTICS TO MONITOR THE NHS CANCER PLAN - REPORT OF A PRE SCOPING STUDY Statistics Commission Report No 2 May Statistics Commission Statistics Commission Report No. 2 National Statistics to
More informationManaging the long-term consequences of sarcoma surgery and treatment at RNOH
Managing the long-term consequences of sarcoma surgery and treatment at RNOH Ruth Carr Macmillan Sarcoma Physiotherapist The Royal National Orthopaedic Hospital, London Sarcoma Service Outline Overview
More informationMacmillan All Wales Patient Information Project. UROLOGY INFORMATION RESOURCE Kidney
This resource provides a listing of good quality information, as and when it is needed. Many of the titles listed are available both as publications and as internet downloads; and some also as audio. Please
More informationEveryone counts Ambitions for GCCG for 7 key outcome measures
Everyone counts s for GCCG for 7 key outcome measures Outcome ambition Outcome framework measure Baseline 2014/15 Potential years of life lost to 1. Securing additional years of conditions amenable to
More informationBRCA Genes and Inherited Breast and Ovarian Cancer. Patient information leaflet
BRCA Genes and Inherited Breast and Ovarian Cancer Patient information leaflet This booklet has been written for people who have a personal or family history of breast and/or ovarian cancer that could
More informationTreatment options for recurrent ovarian cancer
Treatment options for recurrent ovarian cancer There are a number of treatment options for women with recurrent ovarian cancer. Chemotherapy is the treatment most commonly offered and on occasion, surgery
More informationBupa By You. Summary
Bupa By You Summary Find the cover that s right for you There s a lot to take in when purchasing health insurance that s why we ve created this easy to use guide which summarises the cover that s available
More informationTesco Private Healthcare Plan. Effective from 1 March 2016. Administered by Bupa. bupa.co.uk
Tesco Private Healthcare Plan Effective from 1 March 2016 Administered by Bupa bupa.co.uk This is page 1 of 10 which should be read together in full. These pages are for the Tesco Private Healthcare Plan
More informationB&NES Heath & Well-being Partnership. Local Action Plan Implementation of the National Dementia Strategy (NDS) November 2011 Update
B&NES Heath & Well-being Partnership Local Action Plan Implementation of the National Dementia Strategy (NDS) November 2011 Update Who is involved in our action plan? Alzheimer s Society Avon & Wiltshire
More informationMEMBER SUMMARY YOUR LIFE YOUR HEALTH YOUR BENEFIT. SELECT Staff Scheme. Effective from 1 September 2014. bupa.co.uk
MEMBER SUMMARY YOUR LIFE YOUR HEALTH YOUR BENEFIT SELECT Staff Scheme Effective from 1 September 2014 bupa.co.uk Keep this booklet somewhere handy in it, you ll find a summary about the things you re covered
More informationSalisbury Lung Cancer Service (1 of 5)
Salisbury Lung Cancer Service (1 of 5) i If you need this information in another language or medium (audio, large print, etc) please contact Customer Care on 0800 374 208 email: customercare@ salisbury.nhs.uk.
More informationPRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE
PRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE MARCH 2013 MONOGRAPHS IN PROSTATE CANCER OUR VISION, MISSION AND VALUES Prostate Cancer Foundation of Australia (PCFA)
More informationBupa Eduhealth Essentials Healthcare Scheme Bupa private medical cover for the teaching profession and education sector
Bupa Eduhealth Essentials Healthcare Scheme Bupa private medical cover for the teaching profession and education sector Bupa Eduhealth Essentials Healthcare Scheme We re here to help you stay healthy
More informationSnapshot. Co-creating Health. Building new relationships between people with long-term conditions and a supportive health service
Snapshot Co-creating Health Building new relationships between people with long-term conditions and a supportive health service Identify Innovate Demonstrate Encourage What are we doing? We know that people
More informationAppendix D- Monoclonal Gammopathy of Undetermined Significance (MGUS)
Local Enhanced Service: Primary care management of stable haematological patients Monoclonal Gammopathy of Undetermined Significance (MGUS) 1. Introduction Monoclonal Gammopathy of Undetermined Significance
More informationRecommendations for cross-sectional imaging in cancer management, Second edition
www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Breast cancer Faculty of Clinical Radiology www.rcr.ac.uk Contents Breast cancer 2 Clinical background 2 Who
More informationBoard of Directors Meeting
Board of Directors Meeting 23 rd July 2014 (BDA/14/26) part Performance Report Monitor Key Indicators Status: A Paper for Information History: Amanda Pritchard Chief Operating Officer Page 1 of 10 Performance
More informationHSE Transformation Programme. to enable people live healthier and more fulfilled lives. Easy Access-public confidence- staff pride
HSE Transformation Programme. to enable people live healthier and more fulfilled lives Easy Access-public confidence- staff pride The Health Service Executive 4.1 Chronic Illness Framework July 2008 1
More informationUniversity College Hospital. The lung cancer multidisciplinary team. Information for patients and carers
University College Hospital The lung cancer multidisciplinary team Information for patients and carers 2 If you would like this document in another language or format, or require the services of an interpreter,
More informationThe Priory Court Eating Disorder Service
The Priory Court Eating Disorder Service Enhanced outpatient programme PROVIDING QUALITY INSPIRING INNOVATION DELIVERING VALUE Our eating disorder services Priory hospitals are the UK s leading independent
More informationGuidelines for Management of Renal Cancer
Guidelines for Management of Renal Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Changes Between Versions 2 and 3 Section 5 updated bullets 5.3 and 5.4 Section 6 updated
More informationHow To Contact The Lung Cancer And Mesothelioma Multi-Disciplinary Team
Oxford University Hospitals NHS Trust Oxford Lung Cancer and Mesothelioma Multi- Disciplinary Team (MDT) This information leaflet explains the role of the Multi-Disciplinary Team and Specialist Nursing
More informationLean principles and their supporting tools are widely acknowledged to provide an effective framework for
Performance improvement through the application of Lean principles and change management methodology Introduction Lean principles and their supporting tools are widely acknowledged to provide an effective
More informationBreast Health Program
Breast Health Program Working together, for your health. Breast Health Program The Breast Health Program at The University of Arizona Cancer Center offers patients a personalized approach to breast cancer,
More informationRehabilitation Network Strategy 2014 2017. Final Version 30 th June 2014
Rehabilitation Network Strategy 2014 2017 Final Version 30 th June 2014 Contents Foreword 3 Introduction Our Strategy 4 Overview of the Cheshire and Merseyside Rehabilitation Network 6 Analysis of our
More informationUrology Nurse Practitioner Urology Research Nurse Australian Prostate Cancer Research Centre Epworth November 18, 2011
Urology Nurse Practitioner Helen Crowe Urology Nurse Practitioner Urology Research Nurse Australian Prostate Cancer Research Centre Epworth November 18, 2011 Nurse Practitioner Registered nurse who has
More informationInflammatory breast cancer
april 2007 information about Inflammatory breast cancer What is inflammatory breast cancer? Inflammatory breast cancer is a rare and rapidly growing form of breast cancer. Unlike other breast cancers which
More informationDuctal carcinoma in situ (DCIS)
DIAGNOSIS: DCIS Ductal carcinoma in situ (DCIS) This factsheet gives information on an early form of breast cancer called ductal carcinoma in situ (DCIS). It explains what it is, how your breast is made
More informationBOWEL CANCER. The doctor has explained that you have a growth or tumour, in your bowel or rectum and could be cancer.
Patient and Carer Information BOWEL CANCER Please read this leaflet carefully. It is important that you take note of any instructions or advice given. If you have any questions or problems that are not
More informationREPORT ON STOMA SERVICE AND PRACTICE. MM / YY to MM / YY. Name: Title: Centre:
REPORT ON STOMA SERVICE AND PRACTICE MM / YY to MM / YY Name: Title: Centre: 1 Contents 1.0 Introduction 2.0 Aims of the Stoma Care Service 3.0 Clinical Activity 4.0 Cost Saving Measures 5.0 Education
More informationMultidisciplinary Approach to Symptom Management in MS
Multidisciplinary Approach to Symptom Management in MS Emily Cade, M.S., CCM, CRC, CLCP Program Manager Andrew C. Carlos MS Institute Shepherd Center Atlanta, Georgia A Complex Disease A Comprehensive
More informationThe best treatment Your guide to breast cancer treatment in England and Wales
The best treatment Your guide to breast cancer treatment in England and Wales If you are looking for information on the treatment of secondary breast cancer (also known as advanced or metastatic breast
More information